Dosage Reference Table
A comprehensive master reference table consolidating dosing parameters for all peptides in the AMP Peptide Research Database. Includes research dose ranges, administration routes, dosing frequencies, cycle durations, and reconstitution guidelines for each compound.
🔗 Quick Navigation
| Category |
Peptides |
| Neurocognitive |
Semax, Selank, Noopept, Cerebrolysin |
| Sleep & Pineal |
Epitalon, Pinealon |
| Growth & Signaling |
MK-677, Ipamorelin, GHRP-2, GHRP-6, CJC-1295, Sermorelin |
| GLP-1 Agonists |
Tirzepatide, Retatrutide, Semaglutide |
| Cosmetic & Topical |
GHK-Cu, Matrixyl, Argireline, Matrixyl 3000, SNAP-8 |
| Tissue Repair |
BPC-157, TB-500 |
| Mitochondrial |
MOTS-c, SS-31, Humanin, AOD-9604 |
Neurocognitive Peptides
| Parameter |
Semax |
Selank |
Noopept |
Cerebrolysin |
| CAS Number |
80714-61-0 |
129954-34-3 |
157115-85-0 |
N/A (mixture) |
| Dose Range |
200–600 μg |
200–600 μg |
10–20 mg |
5–20 mL |
| Route |
Intranasal |
Intranasal |
Oral / sublingual |
IV / IM |
| Frequency |
1–2× daily |
1–2× daily |
2–3× daily |
3–7× weekly |
| Cycle Duration |
1–3 months |
1–3 months |
1–3 months |
4–12 weeks |
| Washout |
2 weeks |
2 weeks |
1–2 weeks |
Not required |
| Half-life |
~30 min |
~20 min |
~2–5 h |
~4–6 h |
| Solvent |
Bacteriostatic water |
Bacteriostatic water |
Water/saline |
Pre-mixed |
| Storage (Lyophilized) |
−20°C |
−20°C |
2–8°C |
N/A |
| Storage (Reconstituted) |
2–8°C / 7 days |
2–8°C / 7 days |
2–8°C / 14 days |
15–25°C |
Sleep & Pineal Peptides
| Parameter |
Epitalon |
Pinealon |
| CAS Number |
307997-66-2 |
292422-98-9 |
| Dose Range |
5–10 mg |
2–5 mg |
| Route |
Subcutaneous |
Subcutaneous |
| Frequency |
Daily (5–10 days) |
Daily (5–10 days) |
| Cycle Frequency |
2–4× per year |
2–4× per year |
| Dosing Timing |
Evening |
Evening |
| Half-life |
~30–60 min |
~20–40 min |
| Solvent |
Bacteriostatic water |
Bacteriostatic water |
| Storage (Lyophilized) |
−20°C |
−20°C |
| Storage (Reconstituted) |
2–8°C / 7 days |
2–8°C / 7 days |
Growth & Signaling Peptides
| Parameter |
MK-677 |
Ipamorelin |
GHRP-2 |
GHRP-6 |
CJC-1295 |
Sermorelin |
| CAS Number |
159634-47-0 |
170851-70-4 |
157026-82-1 |
142640-99-9 |
863288-34-8 |
86168-78-7 |
| Dose Range |
10–25 mg |
200–500 μg |
100–300 μg |
100–300 μg |
1–2 mg |
200–500 μg |
| Route |
Oral |
SC |
SC |
SC |
SC |
SC |
| Frequency |
Daily |
2–3× daily |
2–3× daily |
2–3× daily |
Every 5–7 days |
Daily |
| Cycle Duration |
12–52 weeks |
8–16 weeks |
8–16 weeks |
8–16 weeks |
8–16 weeks |
12–24 weeks |
| Half-life |
~24 h |
~2 h |
~30 min |
~30 min |
~6–8 days |
~12 min |
| Solvent |
N/A (oral) |
Bacteriostatic water |
Bacteriostatic water |
Bacteriostatic water |
Bacteriostatic water |
Bacteriostatic water |
| Storage (Lyophilized) |
2–8°C |
−20°C |
−20°C |
−20°C |
−20°C |
−20°C |
| Storage (Reconstituted) |
N/A |
2–8°C / 7 days |
2–8°C / 7 days |
2–8°C / 7 days |
2–8°C / 7 days |
2–8°C / 7 days |
GLP-1 Receptor Agonists
| Parameter |
Tirzepatide |
Retatrutide |
Semaglutide |
| CAS Number |
2023788-19-2 |
2381088-14-0 |
910463-68-2 |
| Dose Range |
2.5–15 mg |
2.5–12 mg |
0.25–2.4 mg |
| Route |
SC |
SC |
SC / Oral |
| Frequency |
Weekly |
Weekly |
Weekly (SC) / Daily (oral) |
| Cycle Duration |
12–104 weeks (clinical) |
12–104 weeks |
12–104 weeks |
| Half-life |
~5 days |
~6 days |
~7 days (SC) |
| Solvent |
Bacteriostatic water |
Bacteriostatic water |
Pre-mixed pen |
| Target Receptors |
GIP/GLP-1 dual |
GIP/GLP-1/glucagon triple |
GLP-1 |
Cosmetic & Topical Peptides
| Parameter |
GHK-Cu |
Matrixyl (Pal-Pentapeptide-4) |
Argireline (Acetyl Hexapeptide-8) |
Matrixyl 3000 |
SNAP-8 (Acetyl Octapeptide-3) |
| CAS Number |
89030-95-5 |
214047-00-4 |
616204-22-9 |
214047-00-4 + 823202-99-9 |
868020-15-3 |
| Concentration |
0.5–5% |
2–4% |
5–10% |
3–5% |
5–10% |
| Route |
Topical |
Topical |
Topical |
Topical |
Topical |
| Frequency |
1–2× daily |
1–2× daily |
1–2× daily |
1–2× daily |
1–2× daily |
| pH Range |
5.5–6.5 |
5.5–7.0 |
5.0–6.5 |
5.5–7.0 |
5.0–6.5 |
| Storage |
2–8°C |
15–25°C |
15–25°C |
15–25°C |
15–25°C |
| MW |
~340.8 Da (Cu complex) |
~1064.4 Da |
~888.1 Da |
~1064.4 + 888.1 Da |
~1072.3 Da |
Tissue Repair & Regenerative Peptides
| Parameter |
BPC-157 |
TB-500 (Thymosin Beta-4) |
| CAS Number |
137525-51-0 |
77591-33-4 |
| Dose Range |
200–500 μg |
2.5–10 mg |
| Route |
SC / IM / Oral |
SC / IM |
| Frequency |
1–2× daily |
Every 2–3 days |
| Cycle Duration |
4–12 weeks |
4–12 weeks |
| Half-life |
~4 hours |
~3–5 hours |
| Solvent |
Bacteriostatic water |
Bacteriostatic water |
| Storage (Lyophilized) |
−20°C |
−20°C |
| Storage (Reconstituted) |
2–8°C / 7 days |
2–8°C / 7 days |
| Sequence Length |
15 aa |
43 aa (synthetic fragment) |
| Parameter |
MOTS-c |
SS-31 (Elamipretide) |
Humanin |
AOD-9604 |
| CAS Number |
1627586-91-5 |
736992-11-5 |
330936-69-1 |
221231-10-3 |
| Dose Range |
3–10 mg |
2.5–10 mg |
1–5 mg |
300–600 μg |
| Route |
SC |
SC / IV |
SC |
SC / Oral |
| Frequency |
3–5× weekly |
Daily |
Daily |
Daily |
| Cycle Duration |
4–12 weeks |
4–12 weeks |
4–12 weeks |
8–16 weeks |
| Half-life |
~1–2 hours |
~2 hours |
~1 hour |
~2 hours |
| Solvent |
Bacteriostatic water |
Bacteriostatic water |
Bacteriostatic water |
Bacteriostatic water |
| Storage (Lyophilized) |
−20°C |
−20°C |
−20°C |
2–8°C |
| Storage (Reconstituted) |
2–8°C / 7 days |
2–8°C / 7 days |
2–8°C / 7 days |
2–8°C / 14 days |
📊 Dosing Units Conversion Reference
| Metric |
Microgram (μg) |
Milligram (mg) |
Gram (g) |
| 1 g |
1,000,000 μg |
1,000 mg |
1 g |
| 1 mg |
1,000 μg |
1 mg |
0.001 g |
| 100 μg |
100 μg |
0.1 mg |
0.0001 g |
| 10 μg |
10 μg |
0.01 mg |
0.00001 g |
| 1 μg |
1 μg |
0.001 mg |
0.000001 g |
Insulin Syringe Conversion
| Desired Dose |
5 mg/mL Solution |
2 mg/mL Solution |
1 mg/mL Solution |
| 500 μg |
0.1 mL (10 units) |
0.25 mL (25 units) |
0.5 mL (50 units) |
| 300 μg |
0.06 mL (6 units) |
0.15 mL (15 units) |
0.3 mL (30 units) |
| 200 μg |
0.04 mL (4 units) |
0.1 mL (10 units) |
0.2 mL (20 units) |
| 100 μg |
0.02 mL (2 units) |
0.05 mL (5 units) |
0.1 mL (10 units) |
| 50 μg |
0.01 mL (1 unit) |
0.025 mL (2.5 units) |
0.05 mL (5 units) |
⚠️ Important Notes
- Research use only: All doses listed are for research purposes only and should not be construed as medical recommendations.
- Individual variation: Dosing may require adjustment based on species, weight, sex, age, and health status of research subjects.
- Start low, go slow: Begin with the lower end of the dose range for initial studies and titrate upward as needed.
- Cycle protocols: Include appropriate washout periods between cycles unless continuous administration is indicated.
- Quality control: Always verify peptide purity via COA (Certificate of Analysis) before commencing studies.
🔗 AMP Peptide Product Link
View full product pricing at AMP Peptide